Literature DB >> 11153811

The economic burden of bipolar disease.

S W Woods1.   

Abstract

This article reviews the prevalence of bipolar disorder, as well as the studies quantifying the burden of illness and cost of illness of this condition. It also discusses barriers to treatment. Multiple epidemiologic studies suggest a lifetime prevalence of bipolar I disorder of nearly 1%, making it a common illness. Bipolar illness is not only common, but for those affected, it is a significant source of distress, disability, loss of life through suicide, and burden on relatives and other caregivers. In 1990, the World Health Organization identified bipolar disorder as the sixth leading cause of disability-adjusted life years in the world among people aged 15 to 44 years. Costs to society appear to be roughly 70% of those for schizophrenia. Despite the burden imposed by bipolar illness and the availability of several effective treatments for the illness, many bipolar patients in the United States continue to face significant barriers to care.

Entities:  

Mesh:

Year:  2000        PMID: 11153811

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  34 in total

1.  [Annual costs of bipolar disorders in Germany].

Authors:  C Runge; H Grunze
Journal:  Nervenarzt       Date:  2004-09       Impact factor: 1.214

2.  Misdiagnosis of bipolar disorder.

Authors:  Tanvir Singh; Muhammad Rajput
Journal:  Psychiatry (Edgmont)       Date:  2006-10

Review 3.  Animal models of bipolar disorder and mood stabilizer efficacy: a critical need for improvement.

Authors:  Todd D Gould; Haim Einat
Journal:  Neurosci Biobehav Rev       Date:  2007-05-31       Impact factor: 8.989

Review 4.  Development and Evaluation of a Smartphone-Based Measure of Social Rhythms for Bipolar Disorder.

Authors:  Mark Matthews; Saeed Abdullah; Elizabeth Murnane; Stephen Voida; Tanzeem Choudhury; Geri Gay; Ellen Frank
Journal:  Assessment       Date:  2016-08

5.  Cannabis involvement in individuals with bipolar disorder.

Authors:  Arpana Agrawal; John I Nurnberger; Michael T Lynskey
Journal:  Psychiatry Res       Date:  2010-07-31       Impact factor: 3.222

6.  Elevated striatal reactivity across monetary and social rewards in bipolar I disorder.

Authors:  Sunny J Dutra; William A Cunningham; Hedy Kober; June Gruber
Journal:  J Abnorm Psychol       Date:  2015-09-21

Review 7.  Extended-release carbamazepine capsules : in bipolar I disorder.

Authors:  Tracy Swainston Harrison; Gillian M Keating
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 8.  Cross-species assessments of motor and exploratory behavior related to bipolar disorder.

Authors:  Brook L Henry; Arpi Minassian; Jared W Young; Martin P Paulus; Mark A Geyer; William Perry
Journal:  Neurosci Biobehav Rev       Date:  2010-04-14       Impact factor: 8.989

9.  Predictive factors for time to remission and recurrence in patients treated for acute mania: health outcomes of manic episodes (HOME) study.

Authors:  Kaan Kora; Mete Saylan; Cengiz Akkaya; Nesrin Karamustafalioglu; Nesrin Tomruk; Aziz Yasan; Timucin Oral
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

10.  Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression.

Authors:  Gregory M Sullivan; R Todd Ogden; Maria A Oquendo; J S Dileep Kumar; Norman Simpson; Yung-yu Huang; J John Mann; Ramin V Parsey
Journal:  Biol Psychiatry       Date:  2009-03-17       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.